Insiders Trades
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Latest filing published 15 May 2026 for GENTHERM Inc. Read the official filing
Filing timeline
BuySaleCharles R. Kummeth
Insider track record
Disclosed buys
2
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Charles R. Kummeth: trading record in brief
Filings by Charles R. Kummeth span 4 companies, the busiest being BIO-TECHNE Corp, GENTHERM Inc and Orthofix Medical Inc. The record holds 31 filings, for trades running from 20 May 2021 to 14 May 2026.
The open-market side counts 2 purchases for €506k alongside 4 sales for €11.6M. Netting one side against the other leaves €11.0M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 12 share grants and 12 option exercises. So far in 2026, the count stands at 1 purchase and no sales.
The newest entry dates from 15 May 2026: a share grant, in GENTHERM Inc. The last purchase on record was published on 9 March 2026, which is 223 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles R. Kummeth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
4,292 shares0Common StockSEC:0001193125-26-227290:0
500,000 shares@ US$0.919678.1% of flowClass A Common StockSEC:0001140361-26-008322:0
Canonical exit: 3 Jun 2026 (T+90)
18,841 shares0Common StockSEC:0000950170-25-088993:0
5,075 shares0Common StockSEC:0000950170-25-068169:0
138,900 shares@ US$0.8706100.0% of flowClass A Common StockSEC:0001140361-24-036919:0
Canonical exit: 7 Nov 2024 (T+90)
15,152 shares@ US$12.8762.9% of flowCommon StockSEC:0000950170-24-075305:0
2,662 shares0Common StockSEC:0000950170-24-062513:0
8,350 shares@ US$13.8937.1% of flowCommon StockSEC:0000950170-24-029983:0
17,632 shares0Common StockSEC:0001062993-23-016707:0
9,008 shares0Common StockSEC:0001062993-23-016265:0
31,962 shares@ US$82.173.0% of flowCommon StockSEC:0001062993-23-016040:1
51,516 shares0Common StockSEC:0001062993-23-016040:0
80,000 shares@ US$88.36288.0% of flowCommon StockSEC:0001062993-23-015315:0
616,676 shares@ US$26.6519.1% of flowCommon StockSEC:0001062993-23-014515:0
322 shares@ US$83.000.0% of flowCommon StockSEC:0001062993-23-013263:0
2,147 shares0Common StockSEC:0001209191-23-031459:0
407,364 shares@ US$26.6513.0% of flowCommon StockSEC:0001062993-23-000628:0
16,918 shares0Common StockSEC:0001437749-22-019663:0
11,557 shares@ US$382.975.5% of flowCommon StockSEC:0001437749-22-019663:1
45,346 shares@ US$108.496.1% of flowCommon StockSEC:0001415889-22-008078:0
50,000 shares@ US$108.496.7% of flowCommon StockSEC:0001415889-22-007599:0
5,104 shares@ US$108.490.0076% mcap1.7% of flowCommon StockSEC:0001415889-22-006391:0
1,700 shares0Common StockSEC:0001209191-22-034446:0
938 shares@ US$106.590.1% of flowCommon StockSEC:0001437749-22-002103:0
73,492 shares@ US$108.4910.5% of flowCommon StockSEC:0000914190-21-000360:0
25 of 31 declarations
